Cargando…
Efficient Delivery and Replication of Oncolytic Virus for Successful Treatment of Head and Neck Cancer
Head and neck cancer has been treated by a combination of surgery, radiation, and chemotherapy. In recent years, the development of immune checkpoint inhibitors (ICIs) has made immunotherapy a new treatment method. Oncolytic virus (OV) therapy selectively infects tumor cells with a low-pathogenic vi...
Autores principales: | Hamada, Masakazu, Yura, Yoshiaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582277/ https://www.ncbi.nlm.nih.gov/pubmed/32992948 http://dx.doi.org/10.3390/ijms21197073 |
Ejemplares similares
-
Inhibitors of Ceramide- and Sphingosine-Metabolizing Enzymes as Sensitizers in Radiotherapy and Chemotherapy for Head and Neck Squamous Cell Carcinoma
por: Yura, Yoshiaki, et al.
Publicado: (2020) -
Proteomic Analysis of Secretomes of Oncolytic Herpes Simplex Virus-Infected Squamous Cell Carcinoma Cells
por: Tada, Shinya, et al.
Publicado: (2018) -
Presage of oncolytic virotherapy for oral cancer with herpes simplex virus
por: Yura, Yoshiaki
Publicado: (2017) -
Potential Role of the Intratumoral Microbiota in Prognosis of Head and Neck Cancer
por: Hamada, Masakazu, et al.
Publicado: (2023) -
Induction of autophagy by sphingosine kinase 1 inhibitor PF-543 in head and neck squamous cell carcinoma cells
por: Hamada, Masakazu, et al.
Publicado: (2017)